Last year, EQ introduced readers to the API Innovation Center, located in St. Louis’ Cortex Innovation District. In this short article, Mike Fabrizi reports on continued progress, including a major funding infusion, the opening of a state-of-the-art lab on the University of Missouri at St. Louis (UMSL) campus, and the API Innovation Center’s awarding a contract to a local biosciences firm for the manufacture of key medicines for which there are presently limited or no domestic sources.